GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » Research & Development

Alvotech (Alvotech) Research & Development : $209.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alvotech's Research & Development for the three months ended in Mar. 2024 was $49.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $209.8 Mil.


Alvotech Research & Development Historical Data

The historical data trend for Alvotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Research & Development Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
95.56 148.07 191.01 180.62 210.83

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.86 48.72 53.23 58.01 49.87

Alvotech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $209.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alvotech  (NAS:ALVO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Alvotech Research & Development Related Terms

Thank you for viewing the detailed overview of Alvotech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech (Alvotech) Headlines

From GuruFocus

Alvotech to Participate in Jefferies Healthcare Conference

By GlobeNewswire GlobeNewswire 05-31-2023